Drug Shortage Report for TARO-GLICLAZIDE MR

Last updated on 2020-08-28 History
Report ID 107082
Drug Identification Number 02439328
Brand name RAN-GLICLAZIDE MR
Common or Proper name GLICLAZIDE MR
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) GLICLAZIDE
Strength(s) 60MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-02-21
Estimated end date 2020-07-03
Actual end date 2020-08-18
Shortage status Resolved
Updated date 2020-08-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2020-08-28 French Compare
v13 2020-08-28 English Compare
v12 2020-06-01 French Compare
v11 2020-06-01 English Compare
v10 2020-05-07 French Compare
v9 2020-05-07 English Compare
v8 2020-04-20 French Compare
v7 2020-04-20 English Compare
v6 2020-04-03 French Compare
v5 2020-04-03 English Compare
v4 2020-03-07 French Compare
v3 2020-03-07 English Compare
v2 2020-02-24 French Compare
v1 2020-02-24 English Compare

Showing 1 to 14 of 14